Boston Scientific Corp.
Boston Scientific Corp. (BSX) — Form 10-Q: Quarterly report
AI-generated summary
Boston Scientific Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The filing details the company's financial results and notes that Chairman and CEO Michael F. Mahoney adopted a Rule 10b5-1 trading plan on August 12, 2026, covering the sale of up to 98,814 shares.
Key facts
- Document
- 10-Q
More BSX filings
- 8-K
Filed Oct 28, 2026
- 8-K
Filed Oct 7, 2026
- 8-K
Filed Sep 23, 2026
- 8-K
Filed Sep 8, 2026
- 4
Filed Sep 3, 2026
- 4
Filed Aug 26, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.